Which CAR-T Developer Is the Best Buy?
July 29, 2016 at 13:44 PM EDT
Juno Therapeutics ' (NASDAQ: JUNO) CAR-T cancer research program has been recently plagued by safety concerns, and that could give other companies working on CAR-T therapies an edge.
